Immunogenesis Contact Us
Contact Us – ImmunoGenesis
346-772-0336 WEBContact Us. Are you interested in learning more about our programs? Want to help us change the way people think about cancer? We’d love to hear from you. * * * * Phone Number. 346-772-0336 Phone Number. 346-772-0336: Email. …
See Also: Phone Number Preview / Show details
Who We Are – ImmunoGenesis
WEBImmunoGenesis is an immuno-oncology biopharmaceutical company re-envisioning “cold” tumor treatment. Our deliberate drug development strategy is based in the pathology of …
See Also: Atm Preview / Show details
ImmunoGenesis, Inc. LinkedIn
WEBImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. …
See Also: Atm Preview / Show details
ImmunoGenesis Crunchbase Company Profile & Funding
WEBFounded Date 2019. Founders Michael Curran, William Tanner. Operating Status Active. Last Funding Type Venture - Series Unknown. Legal Name ImmunoGenesis, Inc. …
See Also: Phone Number Preview / Show details
Careers – ImmunoGenesis
346-772-0336 WEBPhone Number. 346-772-0336: Email. info@immunogenesis.com: ImmunoGenesis. JLABS @ TMC 2450 Holcombe Blvd Suite J Houston, TX 77021 . ImmunoGenesis. …
See Also: Phone Number Preview / Show details
ImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of …
WEBSep 28, 2023 · For more information, visit www.immunogenesis.com. Contact. ImmunoGenesis. Investors: James Barlow President and CEO …
See Also: Contact Support Preview / Show details
News – ImmunoGenesis
WEBNov 3, 2022 · June 27, 2023. ImmunoGenesis and Cancer Focus Fund, LP, announce that Cancer Focus Fund plans to invest $4.5 million to support the Phase 1a/1b clinical trial of ImmunoGenesis’ lead …
See Also: Support Number Preview / Show details
ImmunoGenesis Awarded $15.5 M Grant from Cancer Prevention
203-517-8577 WEBAug 24, 2020 · ImmunoGenesis Contact. Bill Tanner CFO 203-517-8577 bill.tanner@immunogenesis.com
See Also: Contact Support Preview / Show details
News – ImmunoGenesis
WEBContact Us; News. There is always something new at ImmunoGenesis. Stay on top of the latest. Press Releases. ImmunoGenesis announces that two poster presentations on …
See Also: Contact Support Preview / Show details
ImmunoGenesis Overview, News & Similar companies
WEBJun 27, 2023 · ImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of IMGS-001 in Relapsed or Refractory Advanced Solid Tumors IMGS-001 is the first dual …
See Also: Phone Number Preview / Show details
ImmunoGenesis Expands R&D, Clinical and Business Development …
WEBJul 28, 2021 · ImmunoGenesis is a clinical-stage biotechnology company developing science-driven immune therapies specifically designed to treat tumors lacking activated …
See Also: Tech Support Preview / Show details
Houston Inno Houston biotech firm adds Csuite roles, opens …
WEBJul 28, 2021 · In August 2020, ImmunoGenesis was awarded $15.5 million from the Cancer Prevention Institute of Texas to advance clinical development for its lead drug …
See Also: Tech Support Preview / Show details
ImmunoGenesis Company Profile 2024: Valuation, Funding
WEBImmunoGenesis General Information Description. Developer of immuno-oncology therapeutics designed to create unparalleled cold tumor treatments. The company …
See Also: Atm Preview / Show details
ImmunoGenesis: Acquisition Strengthens “Cold” Tumor
203-517-8577 WEBDec 9, 2020 · ImmunoGenesis Contact. Bill Tanner Chief Financial Officer 203-517-8577 bill.tanner@immunogenesis.com
See Also: Contact Support Preview / Show details
ImmunoGenesis and Cancer Focus Fund Announce $4.5 Million
WEBJun 27, 2023 · It coincides with ImmunoGenesis' Series A financing, which is expected to close in the third quarter. "Overcoming the widespread resistance to immunotherapy in …
See Also: Phone Number Preview / Show details
ImmunoGenes Crunchbase Company Profile & Funding
WEBFounded Date 2007. Operating Status Active. Last Funding Type Series A. Also Known As ImmunoGenes Kft / ImmunoGenes AG. Company Type For Profit. Contact Email …
See Also: Contact Support Preview / Show details
Data from ImmunoGenesis' Lead Programs to be Presented at …
WEBHOUSTON, Nov. 3, 2021 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotechnology company developing science-driven immune therapies, today announced the …
See Also: Tech Support Preview / Show details